What happened
Merck disclosed an equity stake in Evaxion A/S tied to an AI-powered vaccine program centered on candidate EVX-B3, and licensed EVX-B3 as part of its push into AI-driven vaccine discovery.
Why it matters
This move extends Merck's use of AI beyond traditional pharmaceuticals and mRNA oncology research, aligning with its strategy to build more than 20 potential growth drivers to offset future KEYTRUDA exclusivity risk.
What to watch
Investors should watch whether EVX-B3 progresses into and through clinical trials with clear timelines and disclosed study designs, including updates on patient enrollment, safety data, and movement into later phases.
Summaries like this, in your inbox every morning.
Merck's equity stake in Evaxion and the licensing of EVX-B3 signal a deliberate expansion of its AI-driven discovery playbook. The company is already partnering with Moderna on an mRNA cancer therapy that met key trial endpoints, and this new move into AI-supported vaccine design builds on that momentum. The strategic context is clear: Merck aims to build a pipeline of more than 20 potential growth drivers to cushion against future KEYTRUDA exclusivity risk, and AI-driven vaccine discovery is one avenue to achieve that. Investors should watch for concrete clinical milestones for EVX-B3, such as trial progress and safety data, to gauge execution.
Pick your industry and the AI tools you use, and get news related to your work every day.
Free · 30 seconds with Google · unsubscribe anytimeWhat is AIToday? →
Ask AI anything about this article. The AI reads this article, earlier AIToday articles, and Wikipedia, and cites its sources. Q&As are published on this page for other readers too.
OpenAI introduced the Rosalind Academic Plan, giving eligible academic labs at U.S
Wells Fargo hired an AI executive based in San Francisco, a move The Business Journals describes as part of em…
Amazon launched two Bee "personal AI" devices on Thursday: the $74.99 Bee Frontier wristband and the $99.99 Be…
Apple released MLX today, which runs the 816B-parameter Muse Spark Open on four Mac Studios at over 36 tokens…
Bloom Energy stock fell 4% to $229.83, still up 165% year to date, while Caterpillar slipped 3% to $727.55 and…
LogicMonitor announced its 2026 Elevate Award winners at its Elevate Community Conference in Chicago, honoring…
